{
    "clinical_study": {
        "@rank": "99113", 
        "arm_group": {
            "arm_group_label": "Progel\u00ae Pleural Air Leak Sealant", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The objective of this clinical study is to evaluate the safety of the Progel\u00ae PALS,\n      including the Progel\u00ae Extended Applicator Spray Tips, in sealing or reducing intraoperative\n      air leaks in patients undergoing video assisted or robotic assisted thoracoscopic\n      (VATS/Robotic) surgeries.\n\n      The data collected in this clinical study will supplement the Approved PMA P010047 Progel\u00ae\n      PALS product."
        }, 
        "brief_title": "Progel\u00ae Pleural Air Leak Sealant (PALS) in Video and Robotic Assisted Thoracoscopic Surgery", 
        "completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "condition": "Pulmonary Disease", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Respiration Disorders"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a prospective, open label, multi-center clinical study designed to assess the safety\n      of the Progel\u00ae PALS product, including the Extended Applicator Spray Tip, when used in Video\n      Assisted and Robotic Assisted Thoracoscopic Surgery.  The study will treat approximately 105\n      evaluable subjects at up to 15 U.S. sites.  All subjects will provide informed consent prior\n      to enrollment in the study.\n\n      Patients who have met the initial screening criteria and who have a visible pleural air leak\n      which requires treatment with a sealant, after standard closure techniques are used\n      (standard sutures, staples or devices supplied by the hospital for thoracoscopic surgery)\n      will be eligible for study participation.  If the subject is treated, the surgeon will\n      utilize Progel\u00ae PALS to the same sites originally treated with standard technique."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject is willing and able to provide written informed consent.\n\n          -  Subject is scheduled for video assisted or robotic assisted thoracoscopic surgery for\n             lung resection (i.e. lobectomy, bilobectomy, segmentectomy, and wedge resection/lung\n             volume reduction), decortications or biopsy within 45 days of the screening\n             evaluation.\n\n          -  Subject is \u226518 years of age.\n\n          -  Subject has a life expectancy \u22656 months.\n\n          -  Following lung resection, subject has at least one or more visible intraoperative air\n             leaks, after standard closure techniques are applied, that requires treatment with\n             pleural sealant.\n\n          -  Subject is willing and able to comply with the study procedures and complete the\n             entire study as specified in the protocol, including the follow-up visits.\n\n        Exclusion Criteria:\n\n          -  Subject has undergone previous lung resection or previous use of a sealant for air\n             leaks.\n\n          -  Subject has a serum creatinine \u22652.5 mg/dl at baseline or is currently on dialysis.\n\n          -  Following lung resection, subject has intraoperative air leaks that require\n             non-standard, visceral pleural closure (e.g. leak is too small or tissue is too\n             fragile to use sutures/staples).\n\n          -  Subject has any condition that, in the opinion of the Investigator, would preclude\n             the use of the study device, or preclude the subject from completing the follow-up\n             requirements.\n\n          -  Subject has known allergy to human albumin or any component in the Progel\u00ae PALS\n             product.\n\n          -  Subject has an active or latent infection which is systemic or at the intended\n             surgery site.\n\n          -  Subject has necrotic or friable borders of the defect that will not support secure\n             suture fixation if use of sutures is required.\n\n          -  Subject is participating in another investigational drug or device trial.\n\n          -  Subject is pregnant or has plans to become pregnant during the study period or is\n             currently breastfeeding.\n\n          -  Subject is part of the site personnel directly involved with this study.\n\n          -  Subject is a family member of the investigational study staff."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "112", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 3, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01867658", 
            "org_study_id": "NEO12-102"
        }, 
        "intervention": {
            "arm_group_label": "Progel\u00ae Pleural Air Leak Sealant", 
            "description": "Video-assisted or robotic-assisted surgical lung procedures plus Progel\u00ae Pleural Air Leak Sealant", 
            "intervention_name": "Progel\u00ae Pleural Air Leak Sealant", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Pleural Air Leak", 
            "Pulmonary resection", 
            "Video Assisted", 
            "Robotic Assisted"
        ], 
        "lastchanged_date": "May 21, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Jacksonville", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Cardiothoracic & Vascular Surgical Associates, PA"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jupiter", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Jupiter Medical Center, Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Baptist Hospital of Miami"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Evanston", 
                        "country": "United States", 
                        "state": "Illinois"
                    }, 
                    "name": "North Shore University Health System"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rochester", 
                        "country": "United States", 
                        "state": "Minnesota"
                    }, 
                    "name": "Mayo Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri"
                    }, 
                    "name": "Washington University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lincoln", 
                        "country": "United States", 
                        "state": "Nebraska"
                    }, 
                    "name": "Integrated Cardiology Group, LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hackensack", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }, 
                    "name": "Hackensack University Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York City", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Trustees of Columbia University, NY - Presbyterian Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Greenville", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "Greenville Hospital System"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75246"
                    }, 
                    "name": "Baylor Research Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas"
                    }, 
                    "name": "University of Texas Southwestern Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Falls Church", 
                        "country": "United States", 
                        "state": "Virginia"
                    }, 
                    "name": "INOVA Health Care Services"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madison", 
                        "country": "United States", 
                        "state": "Wisconsin"
                    }, 
                    "name": "Dean Foundation for Health, Research, and Eduation, Inc"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective Multi-Center Clinical Study to Evaluate the Safety of Progel\u00ae Pleural Air Leak Sealant in Video Assisted and Robotic Assisted Thoracotomy Surgery", 
        "overall_official": [
            {
                "affiliation": "Hackensack University Medical Center", 
                "last_name": "Bernard Park, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Dean Foundation for Health, Research and Education, Inc", 
                "last_name": "John Snider, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The primary outcome of the study is the rate of device- and/or procedure-related adverse events at one month after surgery in subjects using Progel\u00ae PALS in a VATS/Robotic procedure. Endpoint analysis of the rate of device- and/or procedure-related adverse events will be based on the Clinical Events Committee (CEC) adjudication of adverse events.", 
            "measure": "Rate of device and/or procedure-related adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "One (1) month follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01867658"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Key Secondary Endpoint", 
                "measure": "Proportion of subjects without postoperative air leaks following lung surgery up to one (1) month follow-up", 
                "safety_issue": "No", 
                "time_frame": "One (1) month"
            }, 
            {
                "measure": "Proportion of air leaks that are sealed or reduced", 
                "safety_issue": "No", 
                "time_frame": "Day 0"
            }, 
            {
                "measure": "Proportion of subjects who are free from air leaks immediately following surgery", 
                "safety_issue": "No", 
                "time_frame": "Day 0"
            }, 
            {
                "measure": "Duration of postoperative air leaks from the time of surgery until the air leak seals", 
                "safety_issue": "No", 
                "time_frame": "Day 0-7"
            }, 
            {
                "measure": "Duration of chest tube drainage", 
                "safety_issue": "No", 
                "time_frame": "Day 0-7"
            }, 
            {
                "measure": "Duration of hospitalization (length of stay)", 
                "safety_issue": "No", 
                "time_frame": "Up to Seven (7) Days"
            }, 
            {
                "measure": "Patient reported Quality of Life as measured by the SF-36", 
                "safety_issue": "No", 
                "time_frame": "One (1) Month"
            }
        ], 
        "source": "C. R. Bard", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "C. R. Bard", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}